User login

We offer our registered users tailored information, free online courses and exclusive content.

Register
You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Manage Diabetes Online

2015 Latin American conference on cardiometabolic diseases management

2015 Latin American conference on cardiometabolic diseases management
  • Cardiometabolic
    Endocrinology and metabolism
  • Diabetes
    Hypertension
    Thyroid disorder
International conference by Excemed
Friday, Jul 3 - Saturday, Jul 4 2015
Santa María Huatulco, Mexico

Accreditation

EACCME®

Tags

cardiovascular disease
Thyroid
Diabetes

Event format

Lecture

Language

The official language of the symposium will be English. Simultaneous translation from English to Spanish will be provided.

Registration status
Closed

To register for this event, contact

Federica Russetti

c/o Meridiano Congress International
T +39 06 88 595 250 - F +39 06 88595 234
federica.russetti@meridiano.it

Registration fee

350.00€

This fee includes:

  • Scientific sessions
  • Educational materials
  • Coffee breaks and luncheons on 03 July and 04 July
  • Dinner on 03 July
  • Certificate of attendance

Introduction

EXCEMED is involved in a comprehensive educational programme to increase knowledge in cardiovascular diseases, diabetes and thyroid disorder, and is proud to organize the 2015 Latin American conference on cardiometabolic diseases management. This meeting will address the most recent  advancements  of  research  in  these  areas  of  cardiometabolic medicine and, in particular, will discuss the best approaches for clinical management of the complexity of cardiometabolic patients in daily practice.

Overview

Cardiovascular diseases, diabetes and thyroid disorders represent the most common pathologies in daily clinical practice and often coexist in the same patient. Diabetes Mellitus, especially type 2, is a growing epidemic in Central and South America as 8.1% of the population (25 million people) in South and Central America has diabetes (6th IDF Atlas). Diabetes management is a big challenge considering the complexity of diabetes pathophysiology and the high healthcare expenditure associated managing diabetes and its complications. Thyroid disorders also impact cardiometabolic health and are prevalent in Latin America, mostly due to iodine deficiency combined with genetic factors. High blood pressure is one of the leading causes of death in the world (Global Burden of Disease study - Lancet 2012) and heart failure is one of the leading causes of hospitalization worldwide with unacceptably high post-discharge mortality and re-hospitalization rates. The prevalence of patients with concomitant heart failure and metabolic disorders, particularly diabetes mellitus and thyroid diseases, continues to increase. Moreover, heart failure patients with concomitant endocrine disorders are a different pathophysiologic population, as peculiar metabolic and neurohormonal abnormalities always coexist in patients with endocrine diseases. Indeed, patients with heart failure and concomitant diabetes have a worse prognosis with increased rates of cardiovascular mortality and post- discharge hospitalization. Taken together, hypertension, heart failure, diabetes and thyroid disorders share common pathophysiologic mechanisms and clinical issues that are often tough tasks to face in clinical practice. EXCEMED is involved in a comprehensive educational programme to increase knowledge in cardiovascular diseases, diabetes and thyroid disorder, and is proud to organize the 2015 Latin American conference on cardiometabolic diseases management. This meeting will address the most recent advancements of research in these areas of cardiometabolic medicine and, in particular, will discuss the best approaches for clinical management of the complexity of cardiometabolic patients in daily practice.

Learning objectives

By attending this live educational symposium, participants will be able to:

  • Understand the pathophysiology linking heart failure, hypertension, diabetes and thyroid disorders

  • Use the correct diagnostic and therapeutic strategies to face difficult cases in clinical practice

  • Consciously apply the most recent guidelines to the management of diabetes and thyroid diseases

  • Manage the complexity of cardiometabolic patients

Accreditation details

An application will be made to the EACCME® for CME accreditation.

This programme is endorsed by Latin American Thyroid Society (LATS)

Scientific programme

Friday, 3 July

08.00 Registration

09.00 Welcome and Introduction

Session I: Heart failure and arterial hypertension: evolving concepts in the pathophysiology and treatment

09.15    L1    Heart rate control in heart failure: old and new drugs, E. Agabiti-Rosei, Italy

09.40    L2    New perspectives on heart failure: Speaker to be announced

10.05    L3    Renal sympathetic denervation therapy for resistant hypertension, A. Coca, Spain

10.30 Question and answer

10.45 Coffee break

Session II: Heart and metabolism: beyond coronary heart disease

11.05    L4   The nature of Type 2 Diabetes: relationships to arterial & cardiac function and heart failure, K. Cruickshank, UK

11.25    L5    Diabetes and heart rate control dysfunction (Cardiac autonomic Neuropathy), E. Maddaloni, USA

11.50    L6    Cardiometabolic implications of thyroid dysfunction, M. Khamaisi, USA

12.20 Question and answer

12.35 Lunch

Session III: Diabetes: prevention and treatment issues

14.00    L7    Pre-diabetes: relevance and treatment, N. Napoli, Italy

14.25    L8    Diabetes management: how to choose the right drug?, R. Castañeda, Mexico

14.50    L9    Diabetes in pregnancy, Speaker to be announced

15.15 Question and answer

15.30 Coffee Break

Session IV: Complications

16.00    L10  Cardiovascular mortality in diabetes, H. Keenan, USA

16.25    L11  Cardiometabolic implications of antidiabetic drugs, Speaker to be announced

16.50    L12  Diabetic osteopathy and the bone-vascular axis, N. Napoli, Italy

17.15 Question and answer

17.30 Take home messages

Concluding remarks

 

Saturday, July 4

Session V: Thyroid: focus on old and new recommendations

09.00    L13  Thyroid nodules in clinical practice: from medical therapy to ultrasonically-guide intervention, Speaker to be announced

09.25    L14  Hypothyroidism and Hyperthyroidism in pregnancy, G. Brenta, Argentina

09.50 Question and answer

Session VI: Debate on hot topics

10.05    D1    Statins and diabetes: Pros, H. Keenan, USA

                    Statins and diabetes: Cons, E. Maddaloni, USA

10.45    D2    Subclinical hypothyroidism: to treat or not to treat? Pros, A. S. Caballero, Mexico

                    Subclinical hypothyroidism: to treat or not to treat? Cons, G. Brenta, Argentina

11.30   Coffee break

Session VII: The complexity of cardiometabolic disease

11.50    L16  Personalised therapy to manage the cardiometabolic patient, K. Cruickshank, UK

12.15    L17  Poly-pharmacotherapy: Compliance and Adherence, N. de La Garza, Mexico

12.40   Question and answer

12.55   Take home message

13.10   Closing remarks from the scientific organiser

13.15   End of the conference

Closing Lunch

 

CME provider

EXCEMED

Salita San Nicola da Tolentino, 1/B 00187 - Rome, Italy

Programme Manager: Giovanna Rossi

Medical Advisor: Ernesto Maddaloni

Chair(s)

Faculty

Enrico Agabiti-Rosei

University of Brescia

Brescia, Italy

 

Gabriela Brenta

Cesar Milstein Hospital

Buenos Aires, Argentina

 

Alejandro Sosa Caballero

Tlacotalpan

Cuauhtémoc Distrito Federal DF

Mexico City, Mexico

 

Rutila Castañeda

Clinical Epidemiology

Research Unit

Hospital General Regional

No 1 Dr Carlos Mac Gregor

 

Sánchez Navarro

Mexico City, D.F., Mexico

 

Antonio Coca

Internal Medicine

Hypertension & Vascular Risk

Unit Hospital Clinic

University of Barcelona

Barcelona, Spain

 

Natalia De la Garza

Universidad Autónoma de Nuevo León

Hospital San José

Centro Médico San Francisco

Monterrey, Nuevo León, Mexico

 

Hillary Keenan

Joslin Diabetes Center

Boston, MA, USA

 

Mogher Khamaisi

Rambam Medical Center

Harvard Medical School

Joslin Diabetes Center

Boston, MA, USA

 

Kennedy Kruickshank

Diabetes & Nutritional Sciences Division

King's College London

London, UK

 

Ernesto Maddaloni

University Campus Bio-Medico

Rome, Italy

Joslin Diabetes Center

(Harvard Medical School)

Boston, MA, USA

 

Nicola Napoli

University Campus Bio-Medico of Rome (UCBM)

Rome, Italy

Registration/Accommodation

Meridiano Congress international

Via Mentana, 2B 00185 Rome, Italy

Congress Coordinator: David H. Slangen
Tel: +39 0688595 209
Fax: +39 0688535 234
david.slangen@meridiano.it

Disclaimer

Disclaimer

latam pic
Publication
Aspetos científicos sobresalientes: Conferencia Latinoamericana sobre tratamiento de la enfermedad cardiometabólica (Spanish)
Cardiometabolic, Endocrinology and metabolism
latam pic
Publication
Destaques científicos: Conferêcia Latino-Americana sobre o tratamento de doenças cardiometabólicas (Portuguese)
Cardiometabolic, Endocrinology and metabolism
Publication
Scientific Highlights: 2015 Latin American conference on cardiometabolic diseases management
Cardiometabolic, Endocrinology and metabolism
Slide kit
Ernesto Maddaloni
Statins and diabetes: Cons
Endocrinology and metabolism
Slide kit
Ernesto Maddaloni
Diabetes and heart rate control dysfunction (Cardiac autonomic Neuropathy)
Endocrinology and metabolism
Video
Nicola Napoli
Pre-diabetes: relevance and treatment
Endocrinology and metabolism
Slide kit
Enrique Gómez
Cardiometabolic implications of antidiabetic drugs
Endocrinology and metabolism
Slide kit
Alejandro Sosa Caballero
Diabetes in pregnancy
Endocrinology and metabolism